# SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours

> **NCT06329323** · — · NOT_YET_RECRUITING · sponsor: **Imperial College London** · enrollment: 24 (estimated)

## Conditions studied

- Germ Cell Ovarian Cancer
- Germ Cell Tumor
- Germ Cell Cancer
- Germ Cell Neoplasia
- Ovary Cancer
- Ovary Neoplasm
- Ovarian Cancer
- Ovarian Neoplasms

## Interventions

- **DIAGNOSTIC_TEST:** Blood test
- **DIAGNOSTIC_TEST:** Pathology specimen miRNA expression

## Key facts

- **NCT ID:** NCT06329323
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-04-14
- **Primary completion:** 2027-04
- **Final completion:** 2028-04
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06329323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06329323, "SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06329323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*